Prime Medicine, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Prime Medicine, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Prime Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $6.83M, a 61.9% increase year-over-year.
  • Prime Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $24.6M, a 104% increase year-over-year.
  • Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.9M, a 115% increase from 2022.
  • Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $6.46M, a 270% increase from 2021.
  • Prime Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.75M, a 347% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $13.9M +$7.45M +115% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 $6.46M +$4.71M +270% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 $1.75M +$1.36M +347% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $391K Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.